MENU
Nkarta (NKTX) Ownership - Who owns Nkarta?
Profile
Industry
N/A
Address
1150 Veterans Boulevard
Phone
+1 905 407-1049
Employees
150
Web
https://www.nkartatx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
382.43M
P/E Ratio
N/A
Total Cash
324.82M
Projected Growth
N/A
Total Debt
85.57M
Revenue
N/A
Risk (Beta)
0.73
Dividend Yield
N/A
Total Cash/Share
4.60
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
NKTX
Capitalization
382M
P/E Ratio
N/A
Risk (Beta)
0.73
Dividend Yield
N/A
Total Cash
325M
Total Cash/Share
4.60
Total Debt
85.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
453M
P/B Ratio
0.84
Cash Flow
N/A
Earnings
-1.97
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
15.91
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-115.21M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-21.95
Shares Held By Institutions
456M
Shares Outstanding - Current
70.6M
Total Liabilities
101M
Total Volume MTD
N/A
Value
1
Gain YTD
-17.879
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1150 Veterans Boulevard
Phone
+1 905 407-1049
Employees
150
Web
https://www.nkartatx.com